VRCA
Verrica Pharmaceuticals Inc
4.50$
-5.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,569.7% | +911.8% | -25.6% | +8.4% | +8.1% | -44.2% | +82.5% | -33.7% | -12.9% | |
| – | +1,569.7% | +903.5% | -28.7% | +4.1% | +9.9% | -47.4% | +98.2% | -34.0% | -16.9% | |
| – | +1,543.8% | +18.6% | -10.0% | +15.6% | +47.4% | +117.6% | +102.9% | -33.4% | -34.9% | |
| – | +1,543.8% | +936.7% | -30.9% | +5.6% | +7.5% | -51.3% | +102.9% | -33.4% | -34.9% | |
| – | – | – | – | – | – | – | +806.8% | -98.3% | +6,909.1% | |
| – | – | – | – | – | – | – | – | +141.0% | -9.2% | |
| – | – | – | +763.1% | +124.4% | -21.1% | -0.2% | – | – | – | |
| – | +402.6% | -84.6% | +37.6% | +1,107.6% | +15.4% | -90.1% | +1,219.0% | +3.5% | -65.0% | |
| – | +47.0% | +302.1% | +35.3% | +1,078.0% | +16.7% | -92.5% | +392.2% | +70.4% | -43.3% | |
| – | -61.1% | – | – | +27,217.7% | +18.1% | -99.3% | +135.7% | +1,843.6% | -94.5% | |
| – | +62.1% | +474.9% | +23.4% | -70.6% | +142.8% | -40.0% | +386.0% | -23.1% | +9.3% | |
| – | – | – | – | – | – | – | – | -27.7% | – | |
| – | – | – | -27.3% | -49.3% | -1.2% | +22.8% | -50.6% | -149.9% | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -3.3% | +0.2% | +0.4% | +8.2% | +26.3% | +32.7% | +14.3% | +105.6% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.